Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,157 | -42,304 | -30,613 | -20,778 | -9,870 |
| Depreciation Amortization | 350 | 997 | 744 | 456 | 231 |
| Accounts receivable | -501 | -258 | 105 | -5 | -461 |
| Accounts payable and accrued liabilities | -1,330 | 2,127 | 1,470 | 2,827 | 1,089 |
| Other Working Capital | 4,285 | -2,338 | 1,008 | 1,326 | 647 |
| Other Operating Activity | 3,729 | 1,027 | 406 | -1,812 | 831 |
| Operating Cash Flow | $-10,624 | $-40,749 | $-26,880 | $-17,986 | $-7,533 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,200 | -6,394 | 2,347 | -3,644 | 1,498 |
| PPE Investments | -242 | -168 | -135 | -134 | -6 |
| Sale Of Investment | 2,225 | 11,761 | 7,848 | 2,100 | 220 |
| Purchase Sale Intangibles | -1,183 | -35 | N/A | N/A | N/A |
| Other Investing Activity | -1,183 | -35 | 0 | 0 | 0 |
| Investing Cash Flow | $4,000 | $5,164 | $10,060 | $-1,678 | $1,712 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 79,345 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 36,305 | N/A | N/A | N/A |
| Other Financing Activity | -20,261 | -796 | -591 | -385 | -186 |
| Financing Cash Flow | $59,084 | $35,509 | $-591 | $-385 | $-186 |
| Exchange Rate Effect | 131 | 94 | 40 | 39 | 16 |
| Beginning Cash Position | 29,023 | 29,005 | 29,005 | 29,005 | 29,005 |
| End Cash Position | 81,614 | 29,023 | 11,634 | 8,995 | 23,014 |
| Net Cash Flow | $52,591 | $18 | $-17,371 | $-20,010 | $-5,991 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,624 | -40,749 | -26,880 | -17,986 | -7,533 |
| Capital Expenditure | -242 | -168 | -135 | -134 | -6 |
| Free Cash Flow | -10,866 | -40,917 | -27,015 | -18,120 | -7,539 |